Welcome to LookChem.com Sign In|Join Free
  • or
2-((2-methoxybenzyl)oxy)ethanol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

33756-81-9

Post Buying Request

33756-81-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

33756-81-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 33756-81-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,7,5 and 6 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 33756-81:
(7*3)+(6*3)+(5*7)+(4*5)+(3*6)+(2*8)+(1*1)=129
129 % 10 = 9
So 33756-81-9 is a valid CAS Registry Number.

33756-81-9Relevant academic research and scientific papers

Nucleophilic Amination of Methoxy Arenes Promoted by a Sodium Hydride/Iodide Composite

Kaga, Atsushi,Hayashi, Hirohito,Hakamata, Hiroyuki,Oi, Miku,Uchiyama, Masanobu,Takita, Ryo,Chiba, Shunsuke

, p. 11807 - 11811 (2017/09/20)

A method for the nucleophilic amination of methoxy arenes was established by using sodium hydride (NaH) in the presence of lithium iodide (LiI). This method offers an efficient route to benzannulated nitrogen heterocycles. Mechanistic studies showed that the reaction proceeds through an unusual concerted nucleophilic aromatic substitution.

NOVEL COMPOUNDS AS INHIBITORS OF RENIN

-

Page/Page column 8-9, (2012/05/20)

The present invention relates to novel renin inhibitors of general formula (1), novel intermediates involved in their synthesis, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to

NOVEL COMPOUNDS AS INHIBITORS OF RENIN

-

Page/Page column 17, (2010/11/05)

The present invention relates to novel renin inhibitors of general formula (1), novel intermediates involved in their synthesis, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to

Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B

Collins, Ian,Caldwell, John,Fonseca, Tatiana,Donald, Alastair,Bavetsias, Vassilios,Hunter, Lisa-Jane K.,Garrett, Michelle D.,Rowlands, Martin G.,Aherne, G. Wynne,Davies, Thomas G.,Berdini, Valerio,Woodhead, Steven J.,Davis, Deborah,Seavers, Lisa C. A.,Wyatt, Paul G.,Workman, Paul,McDonald, Edward

, p. 1255 - 1273 (2007/10/03)

Structure-based drug design of novel isoquinoline-5-sulfonamide inhibitors of PKB as potential antitumour agents was investigated. Constrained pyrrolidine analogues that mimicked the bound conformation of linear prototypes were identified and investigated by co-crystal structure determinations with the related protein PKA. Detailed variation in the binding modes between inhibitors with similar overall conformations was observed. Potent PKB inhibitors from this series inhibited GSK3β phosphorylation in cellular assays, consistent with inhibition of PKB kinase activity in cells.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 33756-81-9